Reversible changes in brain glucose metabolism following thyroid function normalization in hyperthyroidism

American Journal of Neuroradiology

Volumn 32, Issue 6, 2011, Pages 1034-1042

  Miao, Qing ^a   Zhang, Shuo ^a   Guan, Y H ^a   Ye, H Y ^a   Zhang, Z Y ^a   Zhang, Q Y ^a   Xue, R D ^a   Zeng, M F ^a   Zuo, Chuan Tao ^a   Li, Yi Ming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; LIOTHYRONINE; THIAMAZOLE; THYROID HORMONE; THYROXINE;

ADULT; ANXIETY; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFECT; EMOTIONAL STRESS; EUTHYROIDISM; FEMALE; FOLLOW UP; FRONTAL LOBE; FUSIFORM GYRUS; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GRAVES DISEASE; HIPPOCAMPUS; HUMAN; HYPERTHYROIDISM; LIMBIC SYSTEM; MALE; POSITRON EMISSION TOMOGRAPHY; SUPERIOR FRONTAL GYRUS; TEMPORAL LOBE; THYROID FUNCTION; TREATMENT RESPONSE;

ADULT; ANTITHYROID AGENTS; BRAIN; FEMALE; GLUCOSE; HUMANS; HYPERTHYROIDISM; MALE; METHIMAZOLE; TREATMENT OUTCOME;

EID: 79959314818     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2449     Document Type: Article

References (31)

1. Fahrenfort JJ, Wilterdink AM, van der Veen EA. Long-term residual complaints and psychosocial sequelae after remission of hyperthyroidism. Psychoneuroendocrinology 2000;25:201-11 (Pubitemid 29525392)
2. Sait Gonen M, Kisakol G, Savas Cilli A, et al. Assessment of anxiety in subclinical thyroid disorders. Endocr J 2004;51:311-15 (Pubitemid 38981070)
3. Bauer M, Szuba MP, Whybrow PC, eds. Psychiatric and Behavioral Manifestations of Hyper- and Hypothyroidism. Washington, DC: American Psychiatric Press; 2003
4. Schreckenberger MF, Egle UT, Drecker S, et al. Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidism. J Clin Endocrinol Metab 2006;91:4786-91 (Pubitemid 44917308)
5. Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971;12:371-79
6. Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63-70
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 2000
8. Zung WW. From art to science: the diagnosis and treatment of depression. Arch Gen Psychiatry 1973;29:328-37
9. Zung WW, ed. How Normal is Anxiety? Current Concepts. Durham, North Carolina: Upjohn; 1980
10. Sharpley CF, Christie DR. An analysis of the psychometric profile and frequency of anxiety and depression in Australian men with prostate cancer. Psychooncology 2007;16:660-67 (Pubitemid 47180354)
11. Sharpley CF BV, Christie DR. Understanding the causes of depression among prostate cancer patients: development of the Effects of Prostate Cancer on Lifestyle Questionnaire. Psychooncology 2009;18:162-68
12. Schaefer A, Brown J, Watson CG, et al. Comparison of the validities of the Beck, Zung, and MMPI Depression Scales. J Consult Clin Psychol 1985;53:415-18 (Pubitemid 15055093)
13. Wang J, Ma Y, Huang Z, et al. Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease. J Neurol 2009;257:72-78
14. Saxena S, Brody AL, Ho ML, et al. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry 2003;160:522-32 (Pubitemid 41094261)
15. Smith GS, Kramer E, Hermann C, et al. Serotonin modulation of cerebral glucose metabolism in depressed older adults. Biol Psychiatry 2009;66:259-66
16. Lancaster JL, Woldorff MG, Parsons LM, et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 2000;10:120-31 (Pubitemid 30456920)
17. Huang C, Tang C, Feigin A, et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007;130:1834-46 (Pubitemid 47343798)
18. Bhatara VS, Tripathi RP, Sankar R, et al. Frontal lobe proton magnetic-resonance spectroscopy in Graves' disease: a pilot study. Psychoneuroendocrinology 1998;23:605-12 (Pubitemid 28459557)
19. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000;48:813-29
20. Rosen HJ, Levenson RW. The emotional brain: combining insights from patients and basic science. Neurocase 2009;15:173-81
21. Sokoloff L, Wechsler RL, Mangold R, et al. Cerebral blood flow and oxygen consumption in hyperthyroidism before and after treatment. J Clin Invest 1953;32:202-08
22. Sensenbach W, Madison L, Eisenberg S, Ochs L. The cerebral circulation and metabolism in hyperthyroidism and myxedema. J Clin Invest 1954;33:1434-40
23. Fukui T, Hasegawa Y, Takenaka H. Hyperthyroid dementia: clinicoradiological findings and response to treatment. J Neurol Sci 2001;184:81-88 (Pubitemid 32166730)
24. Davidson RJ, Lewis DA, Alloy LB, et al. Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry 2002;52:478-502 (Pubitemid 35284019)
25. Bauer M, Silverman DH, Schlagenhauf F, et al. Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab 2009;94:2922-29
26. Marangell LB, Ketter TA, George MS, et al. Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. Am J Psychiatry 1997;154:224-30 (Pubitemid 27053729)
27. Bench CJ, Friston KJ, Brown RG, et al. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993;23:579-90 (Pubitemid 23268076)
28. Mayberg H. Depression. II. Localization of pathophysiology. Am J Psychiatry 2002;159:1979
29. Wilcoxon JS, Nadolski GJ, Samarut J, et al. Behavioral inhibition and impaired spatial learning and memory in hypothyroid mice lacking thyroid hormone receptor alpha. Behav Brain Res 2007;177:109-16 (Pubitemid 46075154)
30. Mooradian AD, Girgis W, Shah GN. Thyroid hormone-induced GLUT-1 expression in rat cerebral tissue: effect of age. Brain Res 1997;747:144-46 (Pubitemid 27063809)
31. Lass P, Slawek J, Derejko M, et al. Neurological and psychiatric disorders in thyroid dysfunctions: the role of nuclear medicine - SPECT and PET imaging. Minerva Endocrinol 2008;33:75-84